Berkshire Hathaway Restructures Portfolio with Major Stakes in Delta Air Lines and Alphabet State Regulators Challenge Prediction Markets Amid Federal Oversight Debate Roundhill Memory ETF Surpasses 10 Billion in Record Time Amid AI Memory Bottleneck Focus US Political Landscape May Heighten Financial Crisis Vulnerability Analysis Suggests SP 500 Ekes Out Gains as Healthcare Tech Strength Offsets Defensive Weakness Brainbees Solutions Q4 Results Firstcry Parent Narrows Net Loss Revenue Up 12 Tyra Biosciences TYRA Q1 2026 Earnings Net Loss Slightly Wider Than Street Estimates GLIBK Q1 2026 Earnings Significant EPS Miss Sends Stock Lower CDNL Q1 2026 Earnings EPS Surges Past Estimates Revenue Details Absent Stock Slides ChipMOS IMOS Q1 2026 Earnings EPS Misses Expectations as Shares Edge Higher COFS Q1 2026 Earnings EPS Beats Estimates by 55 Amid Mixed Market Reaction Byrna Technologies BYRN Gains 317 as Shares Bounce Off Key Support Aptevo Therapeutics APVO Gains 331 as Stock Approaches Key Resistance Level Essent Group Ltd ESNT Pulls Back 18 as Mortgage Insurer Tests Key Support Zone Nurix Therapeutics Shares Dip Slightly Holds Above Key Support NRIX BWX Technologies BWXT Edges Higher Holding Near Key Resistance at 20923 Veru Inc VERU Gains 216 as Shares Test Key Resistance Level From Porch to Price Tag How Home Affordability Has Slipped Through Generations CSCO Q1 2026 Earnings Earnings Per Share Slightly Beat Estimates Amid Steady Performance AppLovin Shares Surge 104 Following Bullish Analyst Call and Price Target Increase USMCA Talks Commence Amid Looming Tariff Concerns in North America Traders Skeptical of Irans Strait of Hormuz Reopening Timeline Amid Peace Talks San Francisco Real Estate Market Shows Uneven Strength Across Sectors EasyJet Faces Italian Antitrust Probe Over Allegations of Unfair Baggage Pricing Glass Lewis Backs Pacira BioSciences Director Slate Ahead of Annual Meeting Jim Cramer Identifies Three Key Mistakes That May Be Hindering AI Investment Gains Homebuilder Stocks Show Potential Rebound as Technical Patterns Improve INMB Q4 2025 Earnings Narrower Loss Beats Estimates Pipeline Progress Highlighted Iterum Therapeutics ITRM Holds at 003 as Trading Volume Remains Subdued